Printer Friendly

May improve compliance: extended-release ciprofloxacin shown safe, effective in study.

A new once-daily extended-release formulation of ciprofloxacin that could enhance treatment compliance was as safe and effective as conventional twice-daily ciprofloxacin for the treatment of complicated urinary tract infections and acute uncomplicated pyelonephritis in a recent study.

Of 435 patients with a clinical diagnosis of complicated UTI or acute uncomplicated pyelonephritis in the prospective, randomized, double-blind trial, 206 patients received 1,000 mg once-daily ciprofloxacin extended release, and the remaining 229 received 500 mg ciprofloxacin twice daily.

Patients in both groups were treated for 7-14 days, said Dr. David A. Talan of the University of California, Los Angeles, and his colleagues.

The bacteriologic eradication rate was 89% in the once-daily group and 85% in the twice-daily group, and the clinical cure rate was 97% in the once-daily group, and 94% in the twice-daily group (J. Urology 171[2]:734-39, 2004).

Drug-related adverse event rates were similar for the once-daily group and the twice-daily group (13% vs. 14%). Events included nausea, vaginal moniliasis, diarrhea, headache, and dizziness.
DATA WATCH

Chlamydia Rates Rising

Per 100,000 Population

1992 183.4
1994 194.5
1996 193.7
1998 236.7
2000 252.1
2002 296.5

Source: Centers for Disease Control and Prevention

Note: Table made from bar graph.
COPYRIGHT 2004 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Gynecology
Author:Worcester, Sharon
Publication:OB GYN News
Date:Mar 15, 2004
Words:206
Previous Article:Data on cognition: new HT labeling requested by FDA.
Next Article:First reported case: preimplantation dx rules out retinoblastoma.


Related Articles
Extended-release Cipro found effective for UTI. (Study of New Formulation).
Once-daily extended-release ciprofloxacin effective for UTIs. (Rivals Traditional Therapy).
Presumed cystitis can be managed by telephone: large Kaiser experience.
Ciprofloxacin XR for UTIs.
Spectrum Pharmaceuticals Reduces Board Size.
FDA Approves Once-Daily Cipro(R) XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs).

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters